Fulcrum Therapeutics Inc (FULC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 101,597 | 49,628 | 62,452 | 72,797 | 0 |
| TOTAL | $105,222 | $51,366 | $63,996 | $74,095 | $0 |
| Non-Current Assets | |||||
| PPE Net | 9,583 | 10,005 | 10,225 | 10,546 | N/A |
| Other Non-Current Assets | 1,151 | 3,780 | 1,367 | 1,130 | 0 |
| TOTAL | $10,734 | $13,785 | $11,592 | $11,676 | $N/A |
| Total Assets | $115,956 | $65,151 | $75,588 | $85,771 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,533 | 3,081 | 2,522 | 1,263 | 0 |
| Accrued Expenses | 3,583 | 2,793 | 1,699 | 2,497 | 0 |
| TOTAL | $8,585 | $6,343 | $4,690 | $4,229 | $0 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 469 | 469 | 469 | 469 | N/A |
| Other Non-Current Liabilities | 5,243 | 5,353 | 5,449 | 5,542 | 0 |
| TOTAL | $5,243 | $5,353 | $5,449 | $5,542 | $N/A |
| Total Liabilities | $13,828 | $11,696 | $10,139 | $9,771 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 23,341 | 23,340 | N/A | N/A | N/A |
| Common Shares | 23 | 2 | 2 | 2 | 0 |
| Retained earnings | -134,678 | -118,136 | -104,967 | -68,124 | 0 |
| Other shareholders' equity | 0 | 165,136 | 165,136 | 139,670 | 0 |
| TOTAL | $102,128 | $53,455 | $65,449 | $76,000 | $0 |
| Total Liabilities And Equity | $115,956 | $65,151 | $75,588 | $85,771 | $0 |